1Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers[J]. Science JT - Science (New York, N. Y. ), 1990,247:49 -56.
2Vogelstein B,Feoron ER,Hamilton SR, et al. Genetic alteration during colorectal tumor development [J]. NEnglJ Med, 1988,319 . 515-532.
3Cho KR, Vogelstein B. Suppressor gene alterations in the colorectal adenoma-carcinorna sequence. J Cell Bio chem Suppl JT - Journal of cellular biochemistry[J]. Supplement, 1992,16G:137- 141.
5Tanaka K, Oshimura M, Kikuchi R, et al. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18[J]. Nature JT - Nature, 1991,349;340-342.
6Narayanan R, Lawlor KG, Schaapveld RQ, et al. Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-I fibroblasts[J]. Oncogene JT - Oncogene, 1992,7.553-561.
7Mehlen P, Rabizadeh S, Snipas SJ, et al. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis[J]. Nature, 1998,395:801- 804.
8Forcet C, Ye X, Granger L, et al. The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation[J]. Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America, 2001,98 : 3416-3421.
9Kim TH, Lee HK, Seo IA, et al. Netrin induces down-regulation of its receptor, Deleted in Colorectal Cancer, through the ubiquitin-proteasome pathway in the embryonic cortical neuron[J]. J Neurochem JT - Journal of neurochemistry, 2005,95 . 1-8.
10Gao X, Honn K, Grignon D,et at. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas [J].Cancer Res, 1993,53:2723 -2727.
3Wakita K,Kohno N,Sakoda Y,et al.Decreased expression of the DCC gene in human breast cacinoma[J].surgery Today,1996,26:900-903.
4Reale MA,Hu G,Zafar AI,et al.Expression and alternative splicing of the DCCgene in normal and malignant tissue[J].Cancer Res,1994,54:4493-4501.
5Fearon ER,Ekstrand BC,Hu G,et al.Studies of deleted in colorectal cancer in normal and neoplastic tissues[J].Cold spring harbor Symposia on Quantitative Biology,1994,59:637-643.
6Narayanan R,Lawlor KG,Schaapveld RQ,et al.Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts[J].Oncogene,1992,7:553-561.
7Goi T,Yamaguchi A,Nakagawara G,et al.Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers[J].Br J Cancer,1998,77:466-471.
8Shibata D,Real MA,Lavin P,et al.The DCC protein and prognosis in colorectal cancer[J].N Engl J Med,1996 , 335:1727-1732.
9Vogelstein B, Fearon ER, Hamilton SR, et al . Genetic alterations during colorectal tumor development. N Engl J Med, 1988, 319 (9) :525 - 532.
10Fearon ER, Cho KR, Nigro JM, et al . Identification of a chromosome 18 q gene that is altered in colorectal cancers. Science, 1990, 247(4 938) : 49 - 56.
1Kim TH, Lee H K,Seo IA,et al. Netrin induces down regulation of its re- ceptor, Deleted in Colorectal Cancer, through the ubiquitin proteasome pathway in the embryonic cortical neuron [ J J. J Nettrochem J T Journal of neuromistrv, 2005,95 (1):1.
2Sarah Detks, Linch J. W. Bosch et al. Promoter CpG island hypermethyla- tion and H3K9me3 and H3K27me3-mediated epigenetie silencing targets the deleted in colon cancer (DCC) gene in eoloreetal carcinogenesis with- out affecting neighboring genes on chromosomal region 18q21 [J]. Carcino- genesis, 2009,30(6) 1041.
3Andoh T, Chargaff E. Formation and fate of abnormal ribosomes of E. Coli cells treated with 5-fiuorouracil[J]. Proc NaM Acad Sci USA, 1995,54 (4) : 1181.
4Selvakumaran M,Pisareik DA, Bao R. Enhanced cisplatin cytotoxicity by- Disturbing the nucleotide excision repair pathway in ovarian cancer cell lines[J]. Cancer Res,2003,63(6) : 1311.
